Pharmacogenomic Testing

 Pharmacogenomic testing at Revive offers a revolutionary approach to personalized medicine, ensuring that treatments are tailored to an individual’s genetic profile. By analyzing a patient’s DNA, this advanced testing can predict how they will respond to specific medications, helping to maximize therapeutic benefits while minimizing adverse effects. At Revive, the integration of pharmacogenomics into patient care not only enhances the efficacy of treatments but also reduces the trial-and-error process often associated with prescribing medications. This cutting-edge service underscores Revive's commitment to innovative healthcare solutions, providing patients with more precise and effective treatment plans based on their unique genetic makeup.

 Psychotropic: A pharmacogenomic laboratory test which examines fourteen genes that may affect commonly prescribed antidepressant, antipsychotic, anxiolytic, hypnotic, mood stabilizing, stimulant, and non-stimulant medications. 

These tests can be extremely beneficial to providers treating mental health complications. Having these results allows the provider to minimize the trial and error of different medications, leading to more efficient and timely symptom control for patients. 

 If you or someone you know is suffering from a mental health crisis, please reach out for help. You are not alone!! There is help! The suicide and crisis hotline number is 988.